JOHANNESBURG: The U.S. Food and Drug Administration (FDA) has approved Aspen Pharmacare's hydroxyprogesterone caproate (HPC), which is used to prevent preterm birth in pregnant women, the South African drugmaker's CEO said on Thursday.
Enforcement Report - Week of July 10, 2019
Enforcement Report - Week of January 23, 2019
Pfizer Inc. is reviewing options including a sale of its women’s health portfolio as the U.S. pharmaceutical giant seeks to focus on developing treatments with higher growth potential, according to people with knowledge of the matter.
Wistar Institute scientists have found that, in addition to driving breast and ovarian cancer growth, the hormone estrogen plays a role in tamping down the immune response against various cancers. The findings, reported in the journal Cancer Discovery, could result in new combination therapies involving antiestrogen drugs that could increase cancer survival rates.
A growing number of U.S. women are filling prescriptions for unregulated hormones to ease menopause symptoms such as hot flashes and night sweats, a recent study suggests.
The World Health Organization needs more money, more flexibility, and more power to cope with future outbreaks like the Ebola epidemic, according to an independent panel.
NCE Exclusivity Challenges are hot! Hot! HOT! Ferring Lets Loose with the Latest Lawsuit Challenging Denial of NCE Exclusivity for Colon Cleansing Drug
FDA Warns vs 20 Unregistered Drugs
Menopausal HT Not Tied to Greater Death Risk